| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 152,738 | 116,146 | 96,149 | 150,187 | | Cost of Revenue | 131,416 | 101,598 | 87,915 | 136,864 | | | Gross Profit | 21,322 | 14,548 | 8,234 | 13,323 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 26,015 | 26,985 | 21,111 | 38,180 | | Non Recurring | 14,962 | 5,635 | 11,887 | 54,710 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (19,655) | (18,072) | (24,764) | (79,567) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
| 5,555 | | Earnings Before Interest And Taxes | (19,655) | (18,072) | (24,764) | (74,012) | | Interest Expense | 1,298 | 1,811 | 3,196 | 2,502 | | Income Before Tax | (20,953) | (19,883) | (27,960) | (76,514) | | Income Tax Expense | 121 | 19 | 169 | (1,154) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (21,074) | (19,902) | (28,129) | (75,360) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (21,074) | (19,902) | (28,129) | (75,360) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($21,074) | ($19,902) | ($28,129) | ($75,360) |
|
0.02% Nasdaq 0.00%
Income Statement
